An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Electrolyte Emergencies - All Things Potassium Part 1
Potassium disorders can turn weakness into a lethal arrhythmia, and a normal-looking ECG does not rule out dangerous hyperkalemia. The first fork is whether the patient needs immediate cardiac stabilization or controlled replacement.
Also known ashyperkalemia · hypokalemia · dyskalemia · potassium disorders
A 67-year-old man pauses halfway through getting dressed, his legs suddenly too weak to hold him up. His wife says he has barely urinated since yesterday; the bedside monitor now shows a broad, oddly peaked rhythm. His potassium result is still pending, and the team must decide whether to wait for it.
— What’s your move? Read on.
Before you read
What must happen before insulin is used to lower potassium?
When is oral rather than IV potassium replacement appropriate?
When to Think of It
Consider potassium disturbance with weakness, paralysis, palpitations, syncope, renal failure, missed dialysis, tissue breakdown, or use of potassium-altering medications. Hyperkalemia may cause peaked T waves, PR prolongation, loss of P waves, QRS widening, or a sine-wave pattern; hypokalemia may cause flattened T waves, ST depression, U waves, and ectopy. ECG findings are not sensitive enough to exclude danger.
Sick or Not Sick
The decision that matters most: Is there an unstable rhythm or concerning ECG change, or severe potassium abnormality? Treat hyperkalemic ECG toxicity immediately; severe hypokalemia (often <2.5 mEq/L), symptoms, or ECG changes also requires monitored urgent replacement. Confirm unexpected results, but do not delay stabilization for a dangerous ECG.
The First Fifteen Minutes
Hyperkalemia with ECG changes, arrhythmia, or instability → calcium gluconate 1 g IV over 2–5 minutes; repeat ECG and repeat calcium in 5–10 minutes if changes persist. Calcium stabilizes myocardial membranes but does not lower potassium. For peri-arrest or central access, calcium chloride 1 g IV may be used; it is more caustic if extravasated.
Severe hyperkalemia requiring intracellular shift → regular insulin 10 units IV plus dextrose 25 g IV (unless markedly hyperglycemic); insulin shifts potassium into cells. Check glucose frequently for at least 4–6 hours because hypoglycemia can be delayed.
Additional shift for severe hyperkalemia → albuterol 10–20 mg by nebulizer; beta-2 stimulation drives potassium intracellularly. It is an adjunct, not a substitute for calcium or definitive potassium removal.
Hyperkalemia with severe acidemia → sodium bicarbonate 50 mEq IV may be considered when significant metabolic acidemia is present; its benefit is limited otherwise, so follow local protocol and reassess.
Hypokalemia, stable and able to take oral medication → potassium chloride 40 mEq PO, then recheck and repeat according to level and deficit; oral replacement is safer and more predictable.
Hypokalemia requiring IV replacement → potassium chloride 10 mEq/h IV through a peripheral line (up to 20 mEq/h centrally with continuous ECG monitoring and institutional protocol). Never give IV potassium as a push.
Obtain ECG, point-of-care glucose, renal function, magnesium, and repeat potassium if the result is unexpected or hemolysis is suspected. Place patients receiving rapid IV replacement or treatment for severe hyperkalemia on continuous monitoring.
Definitive Care & Disposition
Recheck potassium after temporizing therapy—shifting is not removal. Arrange definitive removal for hyperkalemia: dialysis for refractory or severe cases, particularly with renal failure; potassium binders may be adjuncts but are not reliable emergency monotherapy. Treat the cause (e.g., medication effect, tissue breakdown, or renal failure). Admit to a monitored setting for ECG changes, severe abnormalities, ongoing IV replacement, or need for dialysis; discharge only after stable repeat values, a corrected cause, and a safe follow-up plan.
How This One Kills
Mistaking a temporary intracellular shift for potassium removal. Insulin and albuterol wear off; without repeat testing and definitive elimination, potassium rebounds and the arrhythmia returns.
The Differential — What Else Looks Like This
Pseudohyperkalemia — hemolysis or a difficult draw with a normal ECG and repeat nonhemolyzed sample; treating an artifact can cause dangerous hypokalemia.
Acute coronary syndrome — ischemic ST changes and symptoms rather than a typical potassium progression; confusing it with hyperkalemia delays reperfusion.
Hypomagnesemia — persistent or refractory hypokalemia despite replacement; missing it makes potassium correction ineffective and arrhythmia risk persist.
Periodic paralysis — episodic weakness with potassium shift and often a compatible trigger; large empiric potassium doses can cause rebound hyperkalemia.
The Second-Day Story
Older adults and patients with renal disease may have no palpitations or weakness despite dangerous hyperkalemia; the first clue may be a routine chemistry result or subtle conduction change. Conversely, patients with hypokalemia may report fatigue, constipation, or difficulty walking rather than paralysis. Review renal function, medication and dialysis history, and the ECG, and verify suspicious laboratory results—but never use a reassuring ECG to dismiss a clearly severe potassium level.
Back to Our Patient
Back to our patient: the 67-year-old with oliguria, leg weakness, and broad peaked T waves has a dangerous hyperkalemic ECG pattern, so treatment cannot wait for the pending result. Recognize the likely potassium emergency, risk-stratify him as unstable until proven otherwise, and place him on continuous monitoring while giving IV calcium gluconate, then insulin with dextrose and nebulized albuterol. Repeat ECG and potassium, investigate renal failure and missed dialysis, and arrange urgent definitive potassium removal. He needs monitored admission and likely dialysis, not discharge after a transient ECG improvement.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 67-year-old man presenting with acute leg weakness and markedly reduced urine output since yesterday. His wife reports no known overdose, and he denies chest pain or palpitations, but the monitor shows broad QRS complexes with peaked T waves. He is weak but awake; the ECG is concerning for potassium-related conduction toxicity, and his chemistry is pending. I’m treating presumed severe hyperkalemia now with IV calcium, followed by insulin with dextrose and nebulized albuterol, while monitoring glucose and rhythm. I’ll repeat the ECG and potassium, assess renal function and dialysis history, and involve nephrology early. Given the ECG changes and oliguria, he requires monitored admission and likely urgent dialysis.”
Study Directive
Draw the hyperkalemia ECG progression from memory and state the first action for each dangerous finding.
Practice calculating an insulin/dextrose hyperkalemia order and writing the glucose-monitoring plan.
Review your institution’s potassium infusion limits, monitoring requirements, and escalation pathway for dialysis.
Understanding how the kidney regulates potassium helps residents identify renal causes of dyskalemia and anticipate dangerous shifts when kidney function is impaired.
HHS causes profound dehydration and neurologic dysfunction, often in older adults with comorbid disease. Rapid correction can injure the brain, while...
Also known asHHS · hyperosmolar nonketotic state · HONK · nonketotic hyperglycemia · Hyperosmolar hyperglycemic state · hyperosmolar nonketotic coma
A 76-year-old woman is found sitting on the kitchen floor, too drowsy to finish a sentence. Her lips are dry, and the glass of water beside her is untouched. Her glucose reads “HI,” and her family cannot remember when she last seemed like herself; the next decision is whether fluids or insulin should come first.
Before You Read
Which finding best distinguishes this crisis from DKA?
What must be checked before starting insulin?
How quickly should osmolality fall during treatment?
Why It Matters
HHS causes profound dehydration and neurologic dysfunction, often in older adults with comorbid disease. Rapid correction can injure the brain, while premature insulin can worsen circulatory collapse or provoke hypokalemia.
When to Think of It
Suspect HHS with marked hyperglycemia, dehydration, altered mentation, and little or no ketoacidosis. Current diagnostic criteria include glucose ≥600 mg/dL, effective osmolality >300 mOsm/kg or total osmolality >320 mOsm/kg, minimal ketonemia, and pH ≥7.3 with bicarbonate ≥15 mEq/L. Look for infection, ischemia, medication effects, and limited access to water.
Sick or Not Sick
Is the patient in shock, or is there severe neurologic or cardiopulmonary compromise? Resuscitate and evaluate those patients in a critical-care setting; avoid assuming altered mentation is solely from hyperosmolality.
The First Fifteen Minutes
Volume depletion without heart failure or advanced renal failure → start isotonic crystalloid (0.9% saline or balanced crystalloid) at 500–1,000 mL/h for the first 2–4 hours, reassessing frequently. Fluids restore perfusion and lower glucose; use smaller boluses and close reassessment in older adults or those with cardiac/renal disease.
Check potassium before insulin. If K <3.5 mEq/L → hold insulin and give potassium chloride 10 mEq/h IV per monitoring protocol until K is safe; insulin can drive potassium dangerously lower.
After initial fluids, once K ≥3.5 mEq/L and glucose is not falling adequately → regular insulin 0.05 units/kg/h IV infusion. Insulin reduces hyperglycemia and ongoing osmotic losses; do not give an insulin bolus routinely.
Obtain glucose, electrolytes, BUN/creatinine, venous blood gas, serum beta-hydroxybutyrate, measured or calculated osmolality, ECG, and evaluation for a precipitant. Measure glucose hourly and electrolytes/osmolality about every 2–4 hours during active correction.
Definitive Care & Disposition
Continue volume replacement according to hemodynamics, sodium, urine output, cardiac/renal reserve, and osmolality. Aim for a gradual osmolality decline—roughly 3–8 mOsm/kg/h—and avoid overly rapid glucose reduction; add dextrose-containing fluid as glucose approaches 250 mg/dL while continuing insulin until hyperosmolality resolves. Treat the trigger and monitor for thrombosis, electrolyte shifts, cerebral injury, and fluid overload. HHS generally requires admission; altered mentation, shock, severe comorbidity, or need for close titration warrants ICU-level care.
How This One Kills
Starting insulin before restoring volume and checking potassium. Insulin may worsen hypotension and precipitate life-threatening hypokalemia while the patient remains profoundly depleted.
The Atypical Presentation
Older adults may present with falls, confusion, focal deficits, or inability to manage daily activities rather than thirst or polyuria; access to water may be limited, and medications or infection may obscure the timeline. A seemingly modest mental-status change can coexist with severe hyperosmolality. Check osmolality, ketones, pH, and renal function, and investigate alternative neurologic and infectious causes rather than attributing everything to glucose.
Back to Our Patient
Back to our patient: the 76-year-old with dry lips, confusion, and glucose “HI” has suspected HHS, but the immediate branch is her perfusion and potassium—not the glucose number alone. Assess hemodynamics and neurologic status, begin cautious isotonic fluid resuscitation, and obtain electrolytes, ketones, pH, and osmolality. If potassium is safe and glucose does not fall adequately with fluids, start a low-dose insulin infusion; if potassium is low, replace it first. Admit for close monitoring and gradual correction, escalating to critical care if her mental status or circulation is compromised.
Patient Presentation to Attending
“This is a 76-year-old woman presenting with acute confusion and severe hyperglycemia, with dry mucous membranes and poor oral intake. Her family reports a decline in alertness but no known abrupt focal deficit; I’m evaluating for infection and stroke as well as a hyperglycemic crisis. She appears substantially volume depleted, and I’m obtaining electrolytes, renal function, venous pH, beta-hydroxybutyrate, and osmolality. My leading diagnosis is HHS if testing confirms marked hyperosmolality with minimal ketones and no significant acidosis. I’ll start cautious isotonic fluids, check potassium before insulin, and monitor glucose and osmolality closely. She needs admission, with ICU care if she remains encephalopathic or hemodynamically unstable.”
Study Directive
Calculate effective osmolality for a sample case: 2 × Na + glucose/18.
Compare HHS and DKA criteria from memory, including ketones, pH, bicarbonate, and osmolality.
Rehearse a fluid/insulin sequence for a patient with HHS and low potassium.
Key Medications
Isotonic crystalloid 500–1,000 mL/h initially in adults without significant cardiac or renal limitation; individualize fluid type and rate.
Regular insulin 0.05 units/kg/h IV after initial fluids and once K ≥3.5 mEq/L; dosing and transition targets should follow institutional protocol.
Potassium chloride 10 mEq/h IV when replacement is needed; infusion rates and total replacement depend on access, ECG monitoring, renal function, and local protocol.
Pediatric HHS differs substantially; use a pediatric DKA/HHS protocol.
High-Yield Pearls
HHS can cause focal neurologic findings; do not skip evaluation for stroke.
A falling glucose does not prove osmolality is correcting safely—trend osmolality and sodium.
HHS and DKA can overlap; assess ketones and acid-base status rather than relying on glucose alone.
The Mimics
DKA — substantial ketonemia and metabolic acidosis; misclassifying mixed or DKA physiology can lead to inadequate insulin treatment.
Sepsis — infectious source and inflammatory physiology may explain altered mentation, but missing infection as the HHS trigger delays source control.
Stroke — focal deficit or abrupt onset favors a cerebrovascular event; attributing it to HHS alone delays time-sensitive imaging and treatment.
Uremic encephalopathy — advanced renal dysfunction and compatible metabolic findings; confusing the two can delay dialysis.
Board Question
A patient with HHS has glucose 980 mg/dL, altered mentation, and potassium 3.1 mEq/L. What is the best next step?
AStart regular insulin at 0.1 units/kg/h IV
BGive IV potassium and defer insulin until potassium is safe
CGive sodium bicarbonate IV
DRestrict fluids to prevent cerebral edema
Reveal answer
Correct: B
Insulin can worsen hypokalemia by shifting potassium intracellularly; replace potassium first and begin insulin once K is at least 3.5 mEq/L. Continue carefully titrated fluid resuscitation.
Hypoglycemia is rapidly reversible, but neuroglycopenia can cause seizure, injury, or death. The glucose correction is only the beginning: the cause...
A 58-year-old bus driver grips the steering wheel at a red light, sweating through his shirt and answering the dispatcher with the wrong street name. A passenger notices his hands shaking and flags down help. The glucometer is on its way; the question is whether he can safely swallow.
Before You Read
What is the first treatment decision at the bedside?
When should recurrent hypoglycemia change your disposition plan?
Which drug is useful for sulfonylurea-associated recurrence?
Why It Matters
Hypoglycemia is rapidly reversible, but neuroglycopenia can cause seizure, injury, or death. The glucose correction is only the beginning: the cause determines whether the episode will recur.
When to Think of It
Consider hypoglycemia in altered mental status, diaphoresis, tremor, seizure, focal neurologic symptoms, or unexplained behavioral change—especially in patients using insulin or sulfonylureas. Confirm with bedside glucose when feasible, but treat immediately when symptoms are severe and testing is delayed.
Sick or Not Sick
Can the patient protect their airway and safely swallow? If not, use IV dextrose or glucagon; if yes, give oral carbohydrate. Then determine whether the cause is transient or likely to recur, especially with long-acting insulin, sulfonylureas, renal impairment, poor intake, or intentional overdose.
The First Fifteen Minutes
Awake, cooperative, and able to swallow → give 15–20 g oral glucose, then recheck glucose in 15 minutes and repeat if still low; oral glucose is absorbed quickly.
Unable to swallow or significantly altered, with IV access → give 25 g IV dextrose (e.g., D10W 250 mL or D50W 50 mL); dextrose rapidly restores circulating glucose. Recheck in 15 minutes and repeat or start an infusion if needed.
Unable to swallow and no IV access → give glucagon 1 mg IM or SC; it mobilizes hepatic glycogen, so it may work poorly with depleted glycogen stores or prolonged starvation.
Recurrent hypoglycemia suspected from sulfonylurea → after correction, give octreotide 50–100 mcg SC; it suppresses insulin release and reduces rebound hypoglycemia. Consult poison control/toxicology for repeat dosing and observation guidance.
Check bedside glucose, ECG when indicated, medication history, and likely causes. In an altered patient, protect the airway and do not give oral intake.
Definitive Care & Disposition
Identify and treat the cause: medication dosing or access errors, missed meals, renal/hepatic dysfunction, infection, alcohol use, or intentional ingestion. Recurrent episodes may require a dextrose infusion and serial glucose checks. Observe or admit patients with sulfonylurea exposure, long-acting insulin, recurrence, uncertain cause, inability to eat, significant comorbidity, or intentional overdose; discharge only after sustained euglycemia, safe intake, a clear cause and plan, and reliable follow-up.
How This One Kills
Discharging after one normal glucose. Sulfonylureas and long-acting insulin can produce delayed, recurrent hypoglycemia after the initial correction appears successful.
The Atypical Presentation
Older adults, patients taking beta-blockers, and people with recurrent episodes may lack the expected tremor or palpitations and present with confusion, falls, personality change, or focal deficits. A normal glucose after a snack or prehospital treatment does not exclude an earlier episode or future recurrence. Ask about insulin, sulfonylureas, meals, alcohol, renal function, and access to medications, and repeat glucose after treatment.
Back to Our Patient
Back to our patient: the 58-year-old driver is confused and diaphoretic, so the first bedside decision is whether he can safely swallow. His altered responses make oral treatment unsafe; once the glucometer confirms hypoglycemia, give IV dextrose and recheck in 15 minutes. Review his medication and meal history, monitor for recurrence, and do not let one corrected value end the evaluation. Disposition depends on sustained euglycemia and cause; recurrent or medication-related hypoglycemia warrants observation or admission.
Patient Presentation to Attending
“This is a 58-year-old bus driver brought in for acute confusion and diaphoresis while driving. A passenger noticed hand tremors and incorrect responses; he is not reliably following commands and cannot safely take oral glucose. Bedside glucose is 42 mg/dL, with no persistent focal deficit on the initial exam. I treated with IV dextrose and will repeat glucose in 15 minutes, then reassess his mental status. I’m checking for insulin or sulfonylurea use, missed meals, renal dysfunction, and other causes. He needs observation if glucose recurs or a long-acting medication is involved; discharge requires sustained euglycemia and a safe follow-up plan.”
Study Directive
Practice a one-minute bedside algorithm: confirm glucose, assess swallow/airway, treat, recheck, then identify recurrence risk.
Build a medication history checklist that distinguishes short-acting insulin, long-acting insulin, and sulfonylurea exposure.
Review your local pathway for octreotide use and observation duration after sulfonylurea toxicity.
Key Medications
Oral glucose 15–20 g when awake and safe to swallow.
Dextrose 25 g IV (D10W 250 mL or D50W 50 mL); concentration choice depends on access and local practice.
Glucagon 1 mg IM or SC when IV access is unavailable; intranasal glucagon 3 mg is an alternative where available.
Octreotide 50–100 mcg SC for suspected sulfonylurea-associated recurrent hypoglycemia; repeat dosing varies—consult poison control and an institutional protocol.
Pediatric treatment is weight-based and differs; use a pediatric hypoglycemia protocol.
High-Yield Pearls
In a patient with focal neurologic signs, check glucose early—but reassess for stroke if deficits persist after correction.
Glucagon depends on hepatic glycogen; prolonged fasting, malnutrition, or severe liver disease can blunt its effect.
Rebound after dextrose should raise concern for sulfonylureas or long-acting insulin, not just inadequate initial treatment.
Seizure with postictal state — witnessed convulsion and persistent postictal findings; missing hypoglycemia as a trigger risks recurrence.
Sepsis — infection, fever or hypothermia, and hemodynamic signs; treating only glucose delays source control.
Alcohol intoxication — odor and ataxia may mislead, but low glucose can coexist; assuming intoxication alone risks untreated neuroglycopenia.
Board Question
A patient taking a sulfonylurea presents with hypoglycemia. Glucose improves after IV dextrose but falls again 45 minutes later. Which adjunct best reduces recurrent hypoglycemia?
AOctreotide
BRegular insulin
CGlucagon infusion
DSodium bicarbonate
Reveal answer
Correct: A
Sulfonylureas stimulate pancreatic insulin release, and dextrose alone may trigger further insulin secretion and recurrent hypoglycemia. Octreotide suppresses insulin release; consult poison control for repeat dosing and observation.
An ED-focused guide to correcting low glucose, anticipating recurrence, and deciding when observation or admission is needed.
4 of 4
Mild DKA
Mild DKA still means insulin deficiency, ketone production, and a risk of deterioration. Correctly selected patients may be treated with subcutaneous...
A 24-year-old student sits upright on the edge of the stretcher, sipping water between sentences. She has been nauseated since morning and says her insulin pen ran out two days ago. Her breathing is a little deeper than usual, but she is alert; the lab results will determine whether this is a mild crisis—or one that is already advancing.
Before You Read
Which lab findings establish DKA even when glucose is not extremely high?
When can subcutaneous insulin be used instead of an IV infusion?
What potassium result means insulin must wait?
Why It Matters
Mild DKA still means insulin deficiency, ketone production, and a risk of deterioration. Correctly selected patients may be treated with subcutaneous insulin and close monitoring, but only after dangerous electrolyte deficits and precipitants are addressed.
When to Think of It
DKA is defined by diabetes or hyperglycemia (glucose ≥200 mg/dL or known diabetes), ketonemia (beta-hydroxybutyrate ≥3 mmol/L or urine ketones ≥2+), and metabolic acidosis (pH <7.3 and/or bicarbonate <18 mEq/L). Mild DKA generally includes alert mental status, pH >7.25 to <7.30, and bicarbonate 15–18 mEq/L. Check beta-hydroxybutyrate because glucose can be modest, especially with SGLT2 inhibitors or reduced intake.
Sick or Not Sick
Is the patient stable, alert, and appropriate for a closely monitored subcutaneous pathway—or is there severe acidosis, altered mentation, instability, or a complicating illness? Mild DKA can be considered for ED observation or a step-down setting only if frequent glucose, potassium, and clinical reassessment are reliable.
The First Fifteen Minutes
Volume depleted and without significant cardiac/renal limitation → give isotonic crystalloid 500–1,000 mL/h for the first 2–4 hours, then reassess and individualize. Fluids restore perfusion and reduce counterregulatory stress.
K <3.5 mEq/L → hold insulin and begin potassium chloride 10 mEq/h IV with monitoring and repeat levels; insulin can worsen hypokalemia.
Alert, stable, mild DKA with K ≥3.5 mEq/L and a monitored subcutaneous protocol available → rapid-acting insulin lispro 0.1 units/kg SC every hour or 0.2 units/kg SC every 2 hours, according to local protocol. Frequent subcutaneous dosing can resolve mild DKA without an IV insulin infusion.
Obtain glucose, electrolytes, venous blood gas, beta-hydroxybutyrate, renal function, urinalysis as indicated, and evaluation for precipitating illness. Recheck glucose hourly and electrolytes/ketones about every 2–4 hours.
Definitive Care & Disposition
Continue fluids and protocol-based insulin with serial potassium, bicarbonate, anion gap, and beta-hydroxybutyrate assessment. Add dextrose-containing fluid when glucose falls below about 250 mg/dL so insulin can continue until ketosis resolves. Treat the precipitant and ensure a reliable insulin supply and sick-day plan. Admit or observe where frequent reassessment is available; ICU care is appropriate for severe acidosis, altered mental status, hemodynamic instability, or rapid deterioration. Discharge is unusual and should occur only after resolution and a safe, verified plan.
How This One Kills
Stopping insulin when glucose improves. Glucose can normalize before ketones clear; stopping insulin too early allows ongoing ketogenesis and recurrent acidosis.
The Atypical Presentation
DKA may have only modest glucose elevation, particularly with SGLT2 inhibitors, pregnancy, or reduced food intake; nausea and abdominal pain can overshadow thirst and polyuria. Dehydration and deep breathing may be subtle in early or partially treated disease. Use beta-hydroxybutyrate and acid-base testing rather than excluding DKA based on a glucose value that is not markedly high.
Back to Our Patient
Back to our patient: the 24-year-old with nausea, mild deep breathing, and two days without insulin needs confirmation of ketosis and acidosis, not reassurance from her alert appearance. Her labs show glucose 286 mg/dL, beta-hydroxybutyrate 4.2 mmol/L, pH 7.28, bicarbonate 16 mEq/L, and potassium 4.1 mEq/L—consistent with mild DKA. She is stable and alert, so begin isotonic fluids and use a monitored subcutaneous rapid-acting insulin protocol, with serial glucose and electrolytes. Continue insulin until ketosis resolves, address the insulin-access failure, and admit or observe in a setting able to provide frequent reassessment.
Patient Presentation to Attending
“This is a 24-year-old woman presenting with nausea after running out of insulin two days ago. She is alert and drinking, with mild deep breathing but no hypotension or altered mental status. Glucose is 286, beta-hydroxybutyrate 4.2, venous pH 7.28, bicarbonate 16, and potassium 4.1, consistent with mild DKA. She has no current severe acidosis or instability, making a monitored subcutaneous insulin pathway reasonable. I’ll start isotonic fluids and protocol-based rapid-acting insulin, recheck glucose hourly and electrolytes and ketones serially, and continue treatment until ketosis resolves. She needs monitored observation or admission and a reliable insulin-access plan before discharge.”
Study Directive
Recite the DKA diagnostic triad and mild-DKA severity features without notes.
Work through a sample case: identify the potassium threshold, choose a fluid plan, and select an insulin route.
Review your ED’s subcutaneous DKA pathway and list the monitoring interval and escalation criteria.
Key Medications
Isotonic crystalloid 500–1,000 mL/h initially in adults without significant cardiac or renal limitation; individualize fluid choice and rate.
Rapid-acting insulin lispro 0.1 units/kg SC hourly or 0.2 units/kg SC every 2 hours for a monitored mild-DKA pathway; protocol choice and dosing vary, so check institutional guidance.
Potassium chloride 10 mEq/h IV when K is <3.5 mEq/L, with ECG monitoring and serial potassium; replacement must be individualized for renal function and deficit.
Pediatric DKA management differs; use a pediatric protocol.
High-Yield Pearls
Track beta-hydroxybutyrate and acidosis—not glucose alone—to judge whether DKA has resolved.
A suspected SGLT2-associated DKA can be euglycemic; a modest glucose does not rule it out.
Subcutaneous protocols are for selected stable patients with close monitoring, not a shortcut for unstable or severely acidotic patients.
The Mimics
Starvation ketoacidosis — usually lower glucose and a history of prolonged poor intake; mistaking it for DKA can lead to unnecessary insulin and worsening hypoglycemia.
Alcoholic ketoacidosis — heavy alcohol use, poor intake, and often low or normal glucose; missing it may delay appropriate carbohydrate and fluid treatment.
Lactic acidosis — elevated lactate and a shock, seizure, or sepsis context; treating the number as DKA alone misses the underlying cause.
HHS — profound hyperglycemia and hyperosmolality with minimal ketones and little acidosis; using the wrong pathway can mismanage fluids and insulin.
Board Question
A stable, alert adult with mild DKA has glucose 310 mg/dL, pH 7.27, bicarbonate 16 mEq/L, and potassium 3.1 mEq/L. What is the best next step?
AStart subcutaneous lispro immediately
BStart IV insulin at 0.1 units/kg/h
CReplace potassium and defer insulin until potassium is safe
DGive bicarbonate and discharge when glucose is below 200 mg/dL
Reveal answer
Correct: C
Insulin drives potassium intracellularly and should be deferred when potassium is below 3.5 mEq/L while potassium is replaced and monitored. Once potassium is safe, use an appropriate DKA insulin pathway and treat until ketones and acidosis resolve.
Yesterday’s Differential
The daily puzzle — from editions past
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
A 78-year-old woman presents after a syncopal episode at home, now recovered but shaken, describing weeks of fatigue, dizziness and palpitations. Her telemetry tells a strange story: runs of a fast, narrow-complex junctional tachycardia around 140 bpm abruptly give way to profoun… What’s the diagnosis, and the first move?
Check your answer
Sinus Node Dysfunction (Sick Sinus Syndrome). Capture the rhythm during symptoms with continuous/prolonged monitoring, strip away reversible extrinsic contributors (nonessential AV-nodal drugs, hypothyroidism, electrolyte derangement), and refer for permanent pacemaker only once symptomatic bradycardia is documented to correlate with the ECG.
From the September 28 edition
Today, three days ago: Clevidipine. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
Start 1–2 mg/h IV; double dose at short intervals initially until near goal, then smaller titrations. Typical max 21 mg/h per labeling/protocol. Allergy to soy/egg products, defective lipid metabolism, severe aortic stenosis.
From the September 21 edition
A 78-year-old woman taking digoxin presents with anorexia, confusion, bradycardia, and hypotension. ECG shows high-grade AV block and serum potassium is 6.1 mEq/L. What is the most appropriate next treatment?
AIV calcium chloride alone
BDigoxin immune Fab
CSodium bicarbonate infusion
DImmediate synchronized cardioversion
Reveal answer
Correct · B
Digoxin immune Fab. Life-threatening dysrhythmia, hemodynamic instability, and digoxin-associated hyperkalemia are indications for Fab. Treat temporizing hyperkalemia if necessary, but calcium or cardioversion does not address the toxin and may worsen instability.
Journal Watch
From the FOAMed wire
Notable posts and reviews from the last week, ranked by relevance to today’s lead and source trust.
Brain damage and death from ischemic encephalopathy is common after cardiac arrest. Animal studies and limited observational studies suggest that high oxygen exposure after ROSC may result in neuronal death. As such, it is hypothesized that limiting oxygen exposure (conservative oxygen) many attenuate reperfusion injury and improve outcomes. At present,...
Source
Critical Care Perspectives in Emergency Medicine
Published
2026-09-01
Host
Critical Care Perspectives in Emergency Medicine, Critical Care Perspectives in Emergency Medicine
In this episode, Sam Ashoo, MD and Dr. T.R. Eckler, MD discuss the September 2026 Emergency Medicine Practice article, Emergency Department Diagnosis and Management of Acetaminophen or Salicylate Toxicity 1:13 —...
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
In potassium emergencies, the hyperkalaemia differential separates true excess from impaired renal excretion, transcellular shifts, and pseudohyperkalaemia—a distinction that matters when DKA raises serum potassium despite a total-body deficit.
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Ertapenem
Carbapenem beta-lactam antibiotic without Pseudomonas coverage
Indication
ESBL urinary/intra-abdominal infection when Pseudomonas/Acinetobacter/Enterococcus coverage is not needed; convenient once-daily parenteral therapy planning.
What’s your dose? — reveal dosing & cautions
ED Dose
1 g IV/IM q24h for adults.
Renal Adjustment
CrCl ≤30 or ESRD: 500 mg IV/IM q24h; hemodialysis supplement depends on timing.
Contraindications
Severe carbapenem allergy; IM formulation with lidocaine contraindicated in amide local anesthetic allergy.
Interactions
Valproic acid levels can fall; probenecid increases exposure.
Class III antiarrhythmic with multi-channel effects
Indication
Refractory VF/pulseless VT, stable wide-complex tachycardia, recurrent VT, and selected atrial arrhythmias when other strategies are unsuitable.
What’s your dose? — reveal dosing & cautions
ED Dose
VF/pulseless VT: 300 mg IV/IO bolus, then 150 mg if needed. Stable VT: 150 mg IV over 10 min, may repeat, then infusion 1 mg/min x 6 h then 0.5 mg/min.
Renal Adjustment
No renal adjustment.
Contraindications
Cardiogenic shock, severe sinus-node dysfunction, 2nd/3rd degree AV block without pacer, iodine hypersensitivity is debated but label caution applies.
ECG/QT, BP during infusion, bradycardia, hypotension, liver/thyroid/pulmonary issues for prolonged use.
ED Pearl
Amiodarone in cardiac arrest treats refractory VF/VT; it does not replace high-quality CPR, defibrillation, and fixing the reason the rhythm keeps recurring.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Ischemia
Lateral STEMI
ST elevation in I, aVL and V5-6 is a stand-alone indication for emergent reperfusion, and isolated inferior ST depression may be its only easily visible clue.
The Tracing
A 62-year-old man with hypertension arrives with an hour of left-sided chest heaviness radiating to the jaw. He is diaphoretic; blood pressure 148/90, heart rate 92. The monitor tech hands you the 12-lead and points to the inferior leads, where there is ST depression in III and aVF that first catches your eye. Scanning up to the high lateral leads, you see subtle ST elevation in I and aVL, and following across the precordium there is a hint of ST elevation with fattened, hyperacute T waves in V5 and V6. R wave progression is preserved and there are no Q waves yet. The prior ECG on file, from a clinic visit two years ago, is clean.
Reciprocal ST depression in the inferior leads (III and aVF), seen when there is ST elevation in I and aVL
ST elevation localized to I and aVL defines a high lateral STEMI
Hyperacute T waves in V5-6 may accompany subtle lateral ST elevation
ST elevation in the precordial leads plus the high lateral leads (I and aVL) predicts a proximal LAD lesion 87% of the time
Pearls
Isolated inferior ST depression should make you scrutinize I and aVL for high lateral ST elevation — the reciprocal change is often more obvious than the primary injury current.
Lateral extension of an anterior, inferior or posterior MI marks a larger territory at risk and a worse prognosis, so hunting for lateral involvement changes how sick you consider the patient.
The lateral wall is fed by branches of both the LAD and the circumflex, so the culprit is often a smaller branch — D1, obtuse marginal, or ramus intermedius — that a quick read can dismiss as 'nonspecific.'
Pitfalls
Reciprocal inferior ST depression can be obliterated when there is concomitant inferior ST elevation (inferolateral STEMI), removing your best clue to the lateral injury.
Subtle high lateral ST elevation in I and aVL is easily missed; the inferior reciprocal depression is what makes it visible.
A completed high lateral MI can present with only a pathological Q wave in aVL and T-wave inversion in I and aVL — do not mistake this for an old, benign tracing.
At the Bedside
Treat lateral ST elevation as a STEMI: activate the cath lab for emergent reperfusion and give ACS therapy per your local pathway. Do not wait for anterior or inferior changes to declare it.
For educational use only. Verify ECG interpretation against the LITFL entry and your institution’s practice before clinical decision-making.
Case of the Day
From the lead · Electrolyte Emergencies - All Things Potassium Part 1
Self-Examination
Test Your Understanding
A patient with advanced kidney disease has a potassium of 7.1 mEq/L, QRS widening, and no P waves. Which is the best immediate intervention?
ANebulized albuterol
BIV calcium gluconate
COral potassium binder
DIV furosemide
Reveal answer
Correct answer · B
IV calcium stabilizes the myocardium and is the immediate priority when hyperkalemia causes ECG changes. It does not lower serum potassium, so shifting and definitive removal must follow.
Study Pace* 4 topics today; Issue 79 of 94 — Endocrine (Week 44)Deadline · June 1, 2026